Fortis Healthcare revises London investor meet schedule for Sept 14-15
- Fortis Healthcare revised its London investor meet intimation for September 14-15, 2026
- The non-deal roadshow organized by Jefferies will now feature group meetings instead of one-on-one sessions
- Management from both Fortis Healthcare and IHH Healthcare Berhad will participate in the discussions
- The disclosure was filed under Regulation 30 of SEBI LODR Regulations on September 9, 2026

*this image is generated using AI for illustrative purposes only.
Fortis Healthcare Limited has issued a revised intimation for its non-deal roadshow in London on September 14 and 15, 2026. The company clarified that the meetings will be conducted in a group format rather than one-on-one sessions.
The disclosure, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, updates a previous filing made earlier on September 9, 2026. The event is organized by Jefferies and involves discussions with the management of both Fortis Healthcare Limited and IHH Healthcare Berhad.
Meeting Details
| Date & Time | Event | Mode | Type | Location |
|---|---|---|---|---|
| Sept 14-15, 2026 | Non-deal roadshow | In-person | Group Meet | London |
The meetings are scheduled from 8 am to 5 pm BST (12:30 pm to 9:30 pm IST). The agenda includes general business updates and industry discussions.
Satyendra Chauhan, Company Secretary and Compliance Officer, signed the revised disclosure. The company confirmed that no unpublished price-sensitive information will be shared during the interactions.
Schedules remain subject to change based on investor or company exigencies.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.98% | -5.22% | -13.91% | -3.59% | -26.07% | +179.60% |
How might the shift to group-format meetings influence the depth of engagement with institutional investors compared to previous one-on-one sessions?
What strategic synergies or operational updates regarding the Fortis-IHH partnership are investors likely to prioritize during these London discussions?
Could this non-deal roadshow signal upcoming capital raising activities or strategic restructuring plans for Fortis Healthcare in the near future?


































